Pharmacia Xalcom
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Approvable" letter issued June 2 for combination of Xalatan (latanoprost) and beta blocker timolol (Merck's Timoptic) to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta blockers, prostaglandins or other IOP-lowering medications. The application is receiving priority review. Pharmacia's Xalatan is indicated for open-angle glaucoma and ocular hypertensio